Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
NY Valves 25: Early Clinical and QoL Outcomes of the PASCAL System
Author(s): Santiago Garcia Added: 5 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings… View more

Intervention
Cardiac Denervation as a Treatment for Refractory Ventricular Arrhythmias
Author(s): Carolina Álvarez-Ortega , Josué Daniel Gómez-Martínez , María Alejandra Cardona-Gallardo , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Intervention
EuroPCR 25: The TRINITY Trial
Author(s): Thomas Modine Added: 6 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement… View more

Heart Failure

Intervention
Cardiac Energetics and Systemic Perfusion with VA-ECMO vs ECMELLA
Author(s): Peter Frederiksen , Ann Banke Added: 1 year ago

Intervention
Markus Schlaich
Job title: Renal Physician and Hypertension Specialist
Prof Markus Schlaich (Royal Perth Hospital and University of Western Australia, Perth, AU) is a Renal Physician and an ESH accredited Hypertension Specialist with a strong background in clinical research. His main scientific interests focus on pathophysiologic aspects of hypertension. Prof Schlaich has a specific interest in treatment modalities targeting the sympathetic nervous system and has… View more
TCT 25: PASCAL Precision System in Complex Degenerative MR
Author(s): P Kasi Ramanathan Added: 1 month ago
TCT 2025 - Sub-anlysis findings showed positive safety and efficacy outcomes of the PASCAL Precision system in degenerative mitral regurgitation (DMR) patients.Dr P Kasi Ramanathan (Promedica Toledo Hospital, US) joins us on-site at TCT 2025 to share the findings from a sub-analysis looking at the affect of implant location and leaflet lesion location on the safety and effectiveness of the PASCAL… View more

Intervention
EuroPCR 25: The TRICURE EU Study
Author(s): Julien Dreyfus Added: 6 months ago
EuroPCR 25 - First-in-human outcomes from the TRiCares Topaz Tricuspid Valve Replacement System in patents with tricuspid regurgitation (TR) show positive performance results and improved safety.We are joined by Dr Julien Dreyfus (Centre Cardiologique du Nord, Saint-Denis, FR) to discuss outcomes from the first-in-human, pivotal, multi-centre TRICURE EU study (NCT06581471; TRiCares) investigating… View more

Intervention
The FLEX FIRST AV Registry
Author(s): Ari Kramer Added: 7 months ago
Real-world outcomes from the FLEX Vessel Prep (VP) system in arteriovenous fistulae and grafts show good safety results with no serious adverse events at 30 days and a high six-month primary patency rate.Dr Ari Kramer (Spartanburg Medical Centre, Spartanburg, US) joins us to discuss outcomes from the prospective, multi-centre, observational study using the FLEX FIRST AV registry (NCT05616104;… View more

Intervention

Vascular Disease and Surgery
Revolutionising the Treatment of Severe Tricuspid Regurgitation with the EVOQUE System
Author(s): Philipp Lurz , Jorg Hausleiter , Maria Körber , et al Added: 1 year ago
In this programme, a leading faculty delve into the groundbreaking advancements in the treatment of severe tricuspid regurgitation with the innovative EdwardsEVOQUE Tricuspid Valve Replacement System. This session features an informative "Live in a Box" transcatheter tricuspid replacement valve case by Prof Jörg Hausleiter. It provides a comprehensive analysis of the patient selection criteria,… View more

Intervention
Author(s): Philipp Lurz , Wolfgang Rottbauer , Sam Dawkins , et al Start date: Apr 18, 2024

Intervention